Related Experiment Video
Updated: Jun 5, 2026

Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins
Published on: April 26, 2024
Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections
Julian G Hurdle1, Alex J O'Neill, Ian Chopra
1Department of Biology, University of Texas at Arlington, Arlington, Texas 76019, USA. hurdle@uta.edu
Abstract:
Persistent infections involving slow-growing or non-growing bacteria are hard to treat with antibiotics that target biosynthetic processes in growing cells. Consequently, there is a need for antimicrobials that can treat infections containing dormant bacteria. In this Review, we discuss the emerging concept that disrupting the bacterial membrane bilayer or proteins that are integral to membrane function (including membrane potential and energy metabolism) in dormant bacteria is a strategy for treating persistent infections. The clinical applicability of these approaches is exemplified by the efficacy of lipoglycopeptides that damage bacterial membranes and of the diarylquinoline TMC207, which inhibits membrane-bound ATP synthase. Despite some drawbacks, membrane-active agents form an important new means of eradicating recalcitrant, non-growing bacteria.
Insights
Treating persistent bacterial infections requires new antibiotics. Disrupting bacterial membranes offers a promising strategy against dormant, non-growing bacteria, leading to new antimicrobial development.
Area of Science:
- Microbiology
- Infectious Diseases
- Drug Discovery
Background:
- Persistent bacterial infections are difficult to treat with conventional antibiotics targeting growing cells.
- Dormant or slow-growing bacteria evade current therapies, necessitating novel antimicrobial approaches.
- Bacterial membrane integrity and function are crucial for survival, even in non-growing states.
Purpose of the Study:
- To review emerging strategies for targeting dormant bacteria in persistent infections.
- To explore the potential of disrupting bacterial membrane function as a therapeutic approach.
- To highlight the clinical relevance of membrane-active agents against recalcitrant bacteria.
Main Methods:
- Review of current literature on persistent infections and antimicrobial resistance.
- Analysis of mechanisms of action for membrane-targeting agents.
- Evaluation of clinical data for exemplified therapies like lipoglycopeptides and TMC207.
Main Results:
- Disrupting the bacterial membrane bilayer or integral membrane proteins is a viable strategy against dormant bacteria.
- Membrane-active agents, such as lipoglycopeptides and diarylquinoline TMC207, show efficacy in treating persistent infections.
- These agents target essential membrane functions like potential and energy metabolism in non-growing bacteria.
Conclusions:
- Membrane-active agents represent a significant advancement in combating persistent bacterial infections.
- Targeting bacterial membranes offers a new therapeutic avenue for eradicating dormant and recalcitrant bacteria.
- Further development of these agents is crucial for addressing unmet needs in infectious disease treatment.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Biological Methods for Microbial Control
Inhibitors of Bacterial Protein Synthesis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Determinants of Bacterial Pathogenicity and Virulence

